JR Pharma Engineering Holding ApS — Credit Rating and Financial Key Figures
CVR number: 42396273
Hyldegårds Tværvej 47, 2920 Charlottenlund
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Gross profit | ||||
| EBIT | ||||
| Other financial income | 14.16 | |||
| Other financial expenses | 1.16 | -1.01 | -1.19 | -2.05 |
| Net income from associates (fin.) | 1 201.25 | 650.72 | 591.63 | |
| Pre-tax profit | 1.16 | 1 200.24 | 649.53 | 603.74 |
| Income taxes | 0.22 | -1.76 | ||
| Net earnings | 1.16 | 1 200.46 | 649.53 | 601.98 |
Assets (kDKK)
2022 | 2023 | 2024 | |
|---|---|---|---|
| Intangible assets total | |||
| Tangible assets total | |||
| Holdings in group member companies | 687.23 | 692.66 | 633.57 |
| Investments total | 687.23 | 692.66 | 633.57 |
| Long term receivables total | |||
| Inventories total | |||
| Current other receivables | 2.00 | ||
| Short term receivables total | 2.00 | ||
| Cash and bank deposits | 513.24 | 1 157.33 | 1 816.40 |
| Cash and cash equivalents | 513.24 | 1 157.33 | 1 816.40 |
| Balance sheet total (assets) | 1 200.46 | 1 849.99 | 2 451.97 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Other reserves | 650.72 | 593.57 | ||
| Retained earnings | -1.16 | 549.74 | 1 256.42 | |
| Profit of the financial year | 1.16 | 1 200.46 | 649.53 | 601.98 |
| Shareholders equity total | 1 200.46 | 1 849.99 | 2 451.97 | |
| Non-current liabilities total | ||||
| Current liabilities total | ||||
| Balance sheet total (liabilities) | 1 200.46 | 1 849.99 | 2 451.97 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.